Making the investment case for national regulatory authorities

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 40 X posts from 20 X users, with an upper bound of 76,805 followers.

RT @MSHHealthImpact: In a commentary for @editorjoppp, our MSH colleagues call for greater investment in pharma regulatory systems, which h…

RT @MSHHealthImpact: In a commentary for @editorjoppp, our MSH colleagues call for greater investment in pharma regulatory systems, which h…

RT @MSHHealthImpact: In a commentary for @editorjoppp, our MSH colleagues call for greater investment in pharma regulatory systems, which h…

Very timely!

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 36 additional X posts.